January 22, 2005

Pharmacological Treatment of Dementia: Evidence Report/Technology Assessment

The report, Pharmacological Treatment of Dementia, put together by McMaster University faculty of health sciences to present to the U.S. Department of Health and Human Services. This report provides answers to the following questions: Does pharmacotherapy for dementia syndromes improve cognitive symptoms and outcomes? Does pharmacotherapy delay cognitive deterioration or delay disease onset of dementia syndromes? Are certain drugs, including alternative medicines, more effective than others? Do certain patient populations benefit more from pharmacotherapy than others? What is the evidence base for treatment of ischemic vascular dementia (VaD)? The study also contains data sources, study selection, data extraction, and data synthesis.